Adverse reactions to weight-loss jabs are set to soar by more than 350% in a single year, according to the latest data.

Mounjaro and Ozempic are two medications that can help with diabetes and weight management. But is there a winner in the ...

(Reuters) -A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight ...

Available by prescription (Xenical) and over the counter (Alli), it is often used with a low-fat diet. While effective, ...

The Ohio Board of Pharmacy recently revoked the licenses of four Ohio medical spas, with concerns over the sourcing and ...

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Eli Lilly on Thursday posted better-than-expected quarterly results, although sales of its popular weight-loss drug, Zepbound ...

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...

Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, ...

In today's increasingly competitive market, efficient response and exceptional cost-performance have become crucial for ...